US Stock MarketDetailed Quotes

BDTX Black Diamond Therapeutics

Watchlist
  • 2.515
  • +0.015+0.60%
Trading Dec 13 13:55 ET
142.31MMarket Cap-1.89P/E (TTM)

Black Diamond Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
38.33%-11.32M
-2.49%-14.73M
-5.83%-21.2M
21.59%-66.72M
36.39%-13.96M
-11.45%-18.36M
20.47%-14.37M
29.96%-20.03M
15.04%-85.08M
8.76%-21.94M
Net income from continuing operations
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
27.41%-91.17M
18.51%-21.08M
Operating gains losses
-114.95%-48K
----
----
2,005.88%358K
--0
6,320.00%321K
--0
--37K
342.86%17K
190.00%9K
Depreciation and amortization
-25.22%86K
-24.56%86K
-29.51%86K
-13.98%437K
-31.75%86K
-10.85%115K
-10.94%114K
-2.40%122K
147.80%508K
2.44%126K
Other non cash items
5.65%748K
5.59%737K
5.51%728K
3.08%2.81M
5.43%718K
4.42%708K
1.90%698K
0.58%690K
36.02%2.73M
-1.45%681K
Change In working capital
99.52%2.48M
-83.37%217K
-64.06%-4.57M
137.23%3.69M
184.17%3.93M
-22.97%1.24M
97.13%1.31M
62.92%-2.79M
-241.04%-9.9M
-70.74%-4.66M
-Change in prepaid assets
37.95%927K
-116.75%-176K
-354.05%-973K
122.50%2.27M
-91.62%159K
-22.85%672K
17.17%1.05M
114.46%383K
162.53%1.02M
254.77%1.9M
-Change in payables and accrued expense
74.63%2.36M
53.88%1.57M
-14.83%-2.77M
156.03%4.54M
178.72%4.58M
-6.44%1.35M
120.61%1.02M
42.28%-2.41M
-178.71%-8.09M
-117.74%-5.82M
-Change in other current assets
--44K
----
----
--0
--0
--0
----
----
-82.22%16K
--0
-Change in other current liabilities
-9.32%-856K
-9.44%-835K
-9.28%-824K
-9.61%-3.11M
-9.56%-814K
-9.51%-783K
-9.63%-763K
-9.75%-754K
-64.70%-2.84M
-9.75%-743K
Cash from discontinued investing activities
Operating cash flow
38.33%-11.32M
-2.49%-14.73M
-5.83%-21.2M
21.59%-66.72M
36.39%-13.96M
-11.45%-18.36M
20.47%-14.37M
29.96%-20.03M
15.04%-85.08M
8.76%-21.94M
Investing cash flow
Cash flow from continuing investing activities
105.79%2.19M
-95.69%740K
-155.37%-13.73M
-69.37%16.35M
427.52%12.25M
-361.14%-37.88M
-13.29%17.18M
48.28%24.81M
-59.14%53.37M
-94.63%2.32M
Net PPE purchase and sale
245.45%48K
----
----
133.88%62K
--0
-512.50%-33K
----
----
93.25%-183K
102.70%9K
Net investment purchase and sale
105.67%2.15M
-95.89%702K
-155.37%-13.73M
-69.59%16.28M
429.57%12.25M
-361.06%-37.85M
-14.60%17.08M
48.22%24.81M
-59.84%53.55M
-94.69%2.31M
Cash from discontinued investing activities
Investing cash flow
105.79%2.19M
-95.69%740K
-155.37%-13.73M
-69.37%16.35M
427.52%12.25M
-361.14%-37.88M
-13.29%17.18M
48.28%24.81M
-59.14%53.37M
-94.63%2.32M
Financing cash flow
Cash flow from continuing financing activities
-100.35%-252K
21.38M
7,998.04%4.13M
40,539.55%71.93M
-64.29%-46K
138,221.15%71.93M
0
-66.67%51K
-75.72%177K
-28K
Net common stock issuance
-100.70%-500K
--21.01M
--3.98M
--71.85M
--0
--71.85M
--0
--0
--0
--0
Proceeds from stock option exercised by employees
222.08%248K
--364K
194.12%150K
-53.67%82K
-64.29%-46K
48.08%77K
--0
-66.67%51K
-75.72%177K
---28K
Cash from discontinued financing activities
Financing cash flow
-100.35%-252K
--21.38M
7,998.04%4.13M
40,539.55%71.93M
-64.29%-46K
138,221.15%71.93M
--0
-66.67%51K
-75.72%177K
---28K
Net cash flow
Beginning cash position
-21.99%33.63M
-34.90%26.24M
60.76%57.04M
-47.06%35.48M
6.66%58.8M
-24.42%43.12M
-27.11%40.31M
-47.06%35.48M
87.07%67.02M
15.27%55.13M
Current changes in cash
-159.83%-9.38M
163.34%7.39M
-738.27%-30.8M
168.36%21.56M
91.08%-1.75M
918.00%15.68M
61.23%2.81M
141.18%4.83M
-201.11%-31.54M
-202.34%-19.65M
End cash Position
-58.75%24.25M
-21.99%33.63M
-34.90%26.24M
60.76%57.04M
60.76%57.04M
6.66%58.8M
-24.42%43.12M
-27.11%40.31M
-47.06%35.48M
-47.06%35.48M
Free cash flow
38.45%-11.32M
-2.49%-14.73M
-5.83%-21.2M
21.72%-66.75M
36.39%-13.96M
-11.70%-18.4M
21.31%-14.37M
29.98%-20.03M
17.10%-85.27M
10.01%-21.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 38.33%-11.32M-2.49%-14.73M-5.83%-21.2M21.59%-66.72M36.39%-13.96M-11.45%-18.36M20.47%-14.37M29.96%-20.03M15.04%-85.08M8.76%-21.94M
Net income from continuing operations 32.38%-15.56M-3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M-6.25%-23.01M16.48%-19.15M18.16%-20.88M27.41%-91.17M18.51%-21.08M
Operating gains losses -114.95%-48K--------2,005.88%358K--06,320.00%321K--0--37K342.86%17K190.00%9K
Depreciation and amortization -25.22%86K-24.56%86K-29.51%86K-13.98%437K-31.75%86K-10.85%115K-10.94%114K-2.40%122K147.80%508K2.44%126K
Other non cash items 5.65%748K5.59%737K5.51%728K3.08%2.81M5.43%718K4.42%708K1.90%698K0.58%690K36.02%2.73M-1.45%681K
Change In working capital 99.52%2.48M-83.37%217K-64.06%-4.57M137.23%3.69M184.17%3.93M-22.97%1.24M97.13%1.31M62.92%-2.79M-241.04%-9.9M-70.74%-4.66M
-Change in prepaid assets 37.95%927K-116.75%-176K-354.05%-973K122.50%2.27M-91.62%159K-22.85%672K17.17%1.05M114.46%383K162.53%1.02M254.77%1.9M
-Change in payables and accrued expense 74.63%2.36M53.88%1.57M-14.83%-2.77M156.03%4.54M178.72%4.58M-6.44%1.35M120.61%1.02M42.28%-2.41M-178.71%-8.09M-117.74%-5.82M
-Change in other current assets --44K----------0--0--0---------82.22%16K--0
-Change in other current liabilities -9.32%-856K-9.44%-835K-9.28%-824K-9.61%-3.11M-9.56%-814K-9.51%-783K-9.63%-763K-9.75%-754K-64.70%-2.84M-9.75%-743K
Cash from discontinued investing activities
Operating cash flow 38.33%-11.32M-2.49%-14.73M-5.83%-21.2M21.59%-66.72M36.39%-13.96M-11.45%-18.36M20.47%-14.37M29.96%-20.03M15.04%-85.08M8.76%-21.94M
Investing cash flow
Cash flow from continuing investing activities 105.79%2.19M-95.69%740K-155.37%-13.73M-69.37%16.35M427.52%12.25M-361.14%-37.88M-13.29%17.18M48.28%24.81M-59.14%53.37M-94.63%2.32M
Net PPE purchase and sale 245.45%48K--------133.88%62K--0-512.50%-33K--------93.25%-183K102.70%9K
Net investment purchase and sale 105.67%2.15M-95.89%702K-155.37%-13.73M-69.59%16.28M429.57%12.25M-361.06%-37.85M-14.60%17.08M48.22%24.81M-59.84%53.55M-94.69%2.31M
Cash from discontinued investing activities
Investing cash flow 105.79%2.19M-95.69%740K-155.37%-13.73M-69.37%16.35M427.52%12.25M-361.14%-37.88M-13.29%17.18M48.28%24.81M-59.14%53.37M-94.63%2.32M
Financing cash flow
Cash flow from continuing financing activities -100.35%-252K21.38M7,998.04%4.13M40,539.55%71.93M-64.29%-46K138,221.15%71.93M0-66.67%51K-75.72%177K-28K
Net common stock issuance -100.70%-500K--21.01M--3.98M--71.85M--0--71.85M--0--0--0--0
Proceeds from stock option exercised by employees 222.08%248K--364K194.12%150K-53.67%82K-64.29%-46K48.08%77K--0-66.67%51K-75.72%177K---28K
Cash from discontinued financing activities
Financing cash flow -100.35%-252K--21.38M7,998.04%4.13M40,539.55%71.93M-64.29%-46K138,221.15%71.93M--0-66.67%51K-75.72%177K---28K
Net cash flow
Beginning cash position -21.99%33.63M-34.90%26.24M60.76%57.04M-47.06%35.48M6.66%58.8M-24.42%43.12M-27.11%40.31M-47.06%35.48M87.07%67.02M15.27%55.13M
Current changes in cash -159.83%-9.38M163.34%7.39M-738.27%-30.8M168.36%21.56M91.08%-1.75M918.00%15.68M61.23%2.81M141.18%4.83M-201.11%-31.54M-202.34%-19.65M
End cash Position -58.75%24.25M-21.99%33.63M-34.90%26.24M60.76%57.04M60.76%57.04M6.66%58.8M-24.42%43.12M-27.11%40.31M-47.06%35.48M-47.06%35.48M
Free cash flow 38.45%-11.32M-2.49%-14.73M-5.83%-21.2M21.72%-66.75M36.39%-13.96M-11.70%-18.4M21.31%-14.37M29.98%-20.03M17.10%-85.27M10.01%-21.94M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data